Business ❯Pharmaceutical Industry ❯Market Analysis ❯Sales Projections

Drug Pricing

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

The new drug offers an alternative to opioids for acute pain but demonstrates mixed effectiveness compared to existing treatments.

FDA Approves First New Schizophrenia Drug in Decades